The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Iznak A.F.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN

Iznak E.V.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN

Kalyn Ia.B.

Otdel po izucheniiu bolezni Al'tsgeĭmera i assotsiirovannykh s neĭ rasstroĭstv Nauchnogo tsentra psikhicheskogo zdorov'ia RAMN, Moskva

Safarova T.P.

Sheshenin V.S.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN

Gavrilova S.I.

Otdel po izucheniiu bolezni Al'tsgeĭmera i assotsiirovannykh s neĭ rasstroĭstv Nauchnogo tsentra psikhicheskogo zdorov'ia RAMN, Moskva

Comparative dynamics of EEG parameters in elderly depressive patients during monotherapy and combined therapy

Authors:

Iznak A.F., Iznak E.V., Kalyn Ia.B., Safarova T.P., Sheshenin V.S., Gavrilova S.I.

More about the authors

Read: 908 times


To cite this article:

Iznak AF, Iznak EV, Kalyn IaB, Safarova TP, Sheshenin VS, Gavrilova SI. Comparative dynamics of EEG parameters in elderly depressive patients during monotherapy and combined therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(1):47‑50. (In Russ.)
https://doi.org/10.17116/jnevro20161161147-50

Recommended articles:
Pathogenetic inte­rrelations of hypo­gonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77

References:

  1. Churkin A.A. Epidemiologiya psikhicheskikh rasstroistv. Psikhiatriya. Natsional'noe rukovodstvo. Pod red. Dmitrievoi T.B., Krasnova V.N., Neznanova N.G., Semke V.Ya., Tiganova A.S. M.: GEOTAR-Media; 2009.
  2. Iznak A.F. Neironal'naya plastichnost' kak odin iz aspektov patogeneza i terapii affektivnykh rasstroistv. Psikhiatriya i psikhofarmakoterapiya. 2005;7:1:24-27.
  3. Bogdan A.N., Morozov P.V., Seiku Yu.V. Nootropnye preparaty v kompleksnoi patogeneticheski obosnovannoi terapii depressii (obzor literatury). Psikhicheskie rasstroistva v obshchei meditsine. 2011;3-4:68-73.
  4. Jacobs BL, van Praag H, Gage FH. Depression and the birth and death of brain cells. Am Sci. 2000;88:340-345. doi: 10.1511/2000.4.340.
  5. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorder: implications for the development of novel therapeutics. Psychopharmacol Bull. 2001;35:5-49.
  6. Tatebayashi Y. The dentate gyrus neurogenesis: a common therapeutic target for Alzheimer disease and senile depression? Seishin Shinkeigaku Zasshi. 2003;105:398-404.
  7. Noda Y, Nakamura M, Saeki T, Inoue M, Iwanari H, Kasai K. Potentiation of quantitative electroencephalograms following prefrontal repetitive transcranial magnetic stimulation in patients with major depression. NeuroscienceResearch. 2013;77:1-2:70-77. doi: 10.1016/j.neures.2013.06.002.
  8. Iznak A.F. Neiroprotektory v profilaktike depressivnykh rasstroistv. Sibirskii vestnik psikhiatrii i narkologii (Prilozhenie). 2006;103-105.
  9. Windisch M, Gschanes A, Hutter-Paier B. Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm. 1998;53:289-298. doi: 10.1007/978-3-7091-6467-9_25.
  10. Gavrilova S.I. Vozmozhnosti doklinicheskoi diagnostiki i preventivnogo terapevticheskogo vmeshatel'stva pri bolezni Al'tsgeimera. Psikhiatriya. 2009;1:18-29.
  11. Iznak A.F., Iznak E.V., Zavadenko N.N., Guzilova L.S. Dinamika parametrov komponenta R300 u podrostkov v protsesse terapii astenicheskikh posledstvii cherepno-mozgovoi travmy. Psikhiatriya. 2009;4:25-31.
  12. Iznak E.V., Iznak A.F., Pankratova E.A., Zavadenko N.N., Guzilova L.S., Guzilova Yu.I. Elektrofiziologicheskie korrelyaty effektivnosti nootropnoi terapii posledstvii cherepno-mozgovoi travmy u podrostkov. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2010;110:5:27-32.
  13. Funke M, Fiehler J, Mewes I, Eiselt M, Rother I, Windisch M. Dose-dependent effects of Cerebrolysin on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia. J Neural Transm. 1998;53:385-398. doi: 10.1007/978-3-7091-6467-9_34.
  14. Alvarez XA, Lombardi VR, Corzo L, Perez P, Pichel V, Laredo M, Hernandez A, Freixeiro F, Sampedro C, Lorenzo R, Alcaraz M, Windisch M, Cacabelos R. Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects. J Neural Transm. 2000;59:315-328.
  15. Panteleeva G.P., Artyukh V.V., Krylova E.S., Demeneva A.A., Dikaya T.I., Oleichik I.V., Nikiforova I.Yu., Beburishvili A.A. Tserebrolizin kak sredstvo optimizatsii psikhofarmakoterapii endogennykh depressii. Psikhiatriya. 2008;4-6:70-84.
  16. Ciobanu A, Petcu C, Surdu A. Cerebrolysin augmentation in treatment-resistant depression at elderly. Proc of 10th World Congress of Biological Psychiatry. 2011.
  17. Iznak A.F., Iznak E.V., Kornilov V.V., Kontsevoi V.A. Dinamika neirofiziologicheskikh pokazatelei pri terapii zatyazhnoi psikhogenno sprovotsirovannoi depressii. Psikhiatriya. 2011;1:32-37.
  18. Iznak A.F., Iznak E.V., Yakovleva O.B., Safarova T.P., Kornilov V.V. Neirofiziologicheskie pokazateli effektivnosti terapii depressii pozdnego vozrasta. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112:6:49-54.
  19. Mitrofanov A.A. Komp'yuternaya sistema analiza i topograficheskogo kartirovaniya elektricheskoi aktivnosti mozga s neirometricheskim bankom EEG-dannykh (opisanie i primenenie). M. 2005.
  20. Gorbachevskaya N, Bashina V, Gratchev V, Iznak A. Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study. Brain Dev. 2001;23(suppl 1):90-93. doi: 10.1016/s0387-7604(01)00349-7.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.